|
Current issue
Archive
Manuscripts accepted
About the journal
Editorial board
Abstracting and indexing
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
1/2024
vol. 89 Technology and contrast media
abstract:
Review paper
The use of intravascular contrast media in patients with impaired kidney function – joint clinical practice position statement of the Polish Society of Nephrology and the Polish Medical Society of Radiology
Michał Chmielewski
1, 2
,
Zbigniew Serafin
3
,
Dorota Kamińska
4
,
Katarzyna Skrobisz
5
,
Oliwia Kozak
5
,
Piotr Olczyk
4
,
Przemysław Rutkowski
6
,
Marcin Adamczak
7
,
Edyta Szurowska
5
,
Magdalena Krajewska
5
1.
Department of Nephrology, Transplantology, and Internal Medicine, Medical University of Gdansk, Poland
2.
Department of Rheumatology, Clinical Immunology, Geriatrics, and Internal Medicine, Medical University of Gdansk, Poland
3.
Department of Radiology and Diagnostic Imaging, Nicolaus Copernicus University, Collegium Medicum, Bydgoszcz, Poland
4.
Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Poland
5.
Department of Radiology, Medical University of Gdansk, Poland
6.
Department of Internal and Paediatric Nursing, Faculty of Health Sciences, Medical University of Gdansk, Poland
7.
Department of Nephrology, Transplantation, and Internal Medicine, Medical University of Silesia, Katowice, Poland
Pol J Radiol 2024; 89: e161-e171
Online publish date: 2024/03/21
View full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Radiological procedures utilising intravascular contrast media (ICM) are fundamental to modern medicine, enhancing diagnostics and treatment in diverse medical fields. However, the application of ICM has been constrained in patients with compromised kidney function due to perceived nephrotoxic risks, called contrast-induced nephropathy or contrast-induced acute kidney injury. Historical evidence marked ICM as a possible contributor to kidney damage. This led to restrictive guidelines advocating limited ICM use in patients with impaired renal function, preventing crucial radiographic interventions in patients with acute kidney injury (AKI) and chronic kidney disease. Recent advances challenge these traditional views. In particular, no direct causal relationship has been confirmed between contrast administration and elevated serum creatinine concentrations in humans. Furthermore, contemporary research models and meta-analyses do not associate AKI with contrast usage. This paper, prepared by a cross-disciplinary team of nephrologists and radiologists, presents updated guidelines for ICM application amid renal function impairments, emphasising the reduced nephrotoxic risks currently understood and loosening the previous restrictive approach in patients with renal dysfunction.
keywords:
intravascular contrast media, chronic kidney disease, acute kidney injury, position statement |
   |
